Mechanical thrombectomy was associated with better survival outcomes across patient risk categories and time-to-treatment.

Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...

For people with stroke, social factors such as race, neighborhood and insurance, may be linked to whether they receive ...

There are clinical benefits up to 1 year following endovascular thrombectomy for treatment of acute basilar artery occlusion.

Professor Powis, alongside the National Clinical Director for Stroke David Hargroves and regional/national colleagues, spent ...

New research shows young adults face large vessel occlusion strokes, once seen mostly in older adults, due to rising stroke ...

A new Harvey L. Neiman Health Policy Institute study found that neurointerventionalists, who often deliver lifesaving and ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The TESLA trial was unable to support a benefit to thrombectomy for stroke patients with large-core infarcts identified ...

Surmodics, Inc. SRDX received the FDA’s 510(k) clearance for its Pounce XL Thrombectomy System yesterday. Following the ...

Tenecteplase is a third-generation thrombolytic agent that has a favourable pharmacological profile, compared with alteplase. Tenecteplase has a longer half-life, which allows administration in a ...

The latest news from the lab, plus an analyst's bullish move, combined to put some zip in the company's shares.